President Trump’s nominee for White House Drug Czar, who is expected to be confirmed soon by the Senate Judiciary Committee, has expressed strong support for medical marijuana and an openness to nationwide rescheduling. Sara Carter, Trump’s pick to lead the White House Office of National Drug Control Policy (often called the “Drug Czar”), appeared yesterday before the Senate Judiciary Committee for her confirmation hearing. Carter called rescheduling a “bipartisan issue” and stressed her commitment to relying on research and data. The Senate Judiciary Committee is expected to vote in the coming days. If confirmed, Carter would inherit an office historically tasked with opposing legalization efforts but would do so at a time when 24 states have legalized recreational marijuana and 40 have legalized medical use.